Efficacy and Safety of Rimegepant for Acute Dizziness
Clinical trial NCT07435090 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07435090
- Sponsor
- Shi Tianming
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-20
- Primary completion
- 2027-12-31
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.